A study on local application of drug named 5-fluorouracil after removal of cyst by the name of Odontogenic keratocyst in jaws

Phase 4

Not yet recruiting

• Conditions: Health Condition 1: O- Medical and Surgical

• Registration Number: CTRI/2024/03/063854
• Lead Sponsor: Dr Priyanka Shetty

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 1 April 2024

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1) All the histopathologically diagnosed cases of Odontogenic Keratocyst reporting in OPD.

2) All patients willing and fit for surgery.

3) All the cases who are undergoing treatment for the 1st time as well as the recurrent cases

Exclusion Criteria

1) Patients with diagnoses other than Odontogenic Keratocyst reporting in OPD

2) Patients unwilling and unfit for surgery.

3) Patients who are lost to follow up.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1) Nerve Paresthesia <br/ ><br>2) Healing of Cyst <br/ ><br>3) Radiographic Recurrence of CystTimepoint: 1) Nerve Paresthesia - pre-op,post-op, 15 days, 1 month, 3 months, 6 months, 1 yr, 1yr 6 months, 2 years. <br/ ><br>2) Healing of Cyst - pre-op,post-op, 15 days, 1 month, 3 months, 6 months, 1 yr, 1yr 6 months, 2 years. <br/ ><br>3) Radiographic Recurrence of Cyst - pre-op,post-op, 15 days, 1 month, 3 months, 6 months, 1 yr, 1yr 6 months, 2 years.

Secondary Outcome Measures

Name	Time	Method
Volumetric Analysis of the cystTimepoint: Pre-op - S0 <br/ ><br>6 months post op - S1 <br/ ><br>12 months post op - S2